Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (601-610 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|July 14, 2018
Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and StatinsDorota Danielak, Marta Karaźniewicz-Łada, Franciszek Główka
Drugs|July 14, 2018
Correction to: Nonacog Beta Pegol: A Review in Haemophilia BYahiya Y Syed
Drugs|July 4, 2018
The Future of IL-1 Targeting in Kidney DiseaseBaris Afsar, Adrian Covic, Alberto Ortiz, et al.
Drugs|January 1, 1985
History of the development of inhibitors of angiotensin I conversionS H Ferreira
Drugs|September 30, 2018
Lanadelumab: First Global ApprovalYahiya Y Syed
Drugs|May 18, 2019
Teriflunomide: A Review in Relapsing-Remitting Multiple SclerosisLesley J Scott
Drugs|May 18, 2019
Correction to: Pegaspargase: A Review in Acute Lymphoblastic LeukaemiaYoung-A Heo, Yahiya Y Syed, Susan J Keam
Drugs|July 1, 1978
Drug-induced liver diseaseH J Zimmerman
Drugs|March 7, 2022
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent PainMarco Sisignano, Philip Gribbon, Gerd Geisslinger
Drugs|April 1, 2022
Clazosentan: First ApprovalArnold Lee
Pageof 708

Showing results (601-610 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|July 14, 2018
Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and StatinsDorota Danielak, Marta Karaźniewicz-Łada, Franciszek Główka
Drugs|July 14, 2018
Correction to: Nonacog Beta Pegol: A Review in Haemophilia BYahiya Y Syed
Drugs|July 4, 2018
The Future of IL-1 Targeting in Kidney DiseaseBaris Afsar, Adrian Covic, Alberto Ortiz, et al.
Drugs|January 1, 1985
History of the development of inhibitors of angiotensin I conversionS H Ferreira
Drugs|September 30, 2018
Lanadelumab: First Global ApprovalYahiya Y Syed
Drugs|May 18, 2019
Teriflunomide: A Review in Relapsing-Remitting Multiple SclerosisLesley J Scott
Drugs|May 18, 2019
Correction to: Pegaspargase: A Review in Acute Lymphoblastic LeukaemiaYoung-A Heo, Yahiya Y Syed, Susan J Keam
Drugs|July 1, 1978
Drug-induced liver diseaseH J Zimmerman
Drugs|March 7, 2022
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent PainMarco Sisignano, Philip Gribbon, Gerd Geisslinger
Drugs|April 1, 2022
Clazosentan: First ApprovalArnold Lee
Pageof 708